Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513256645> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W2513256645 endingPage "237" @default.
- W2513256645 startingPage "234" @default.
- W2513256645 abstract "Talimogene laherparepvec (T-VEC) is the first (approved recently in the European Union) oncolytic immunotherapy which demonstrated therapeutic benefit for cutaneous melanoma in a phase III clinical trial. This resulted in a higher that previously obtainable response rate and median overall survival, particularly in untreated patients or those with stage IIIB, IIIC, or IVM1a disease. T-VEC was well tolerated and is currently studied in combined therapy with immunological checkpoints and in a neoadjuvant setting. In the review, current data on its efficacy and safety in melanoma therapy are discussed." @default.
- W2513256645 created "2016-09-16" @default.
- W2513256645 creator A5052149622 @default.
- W2513256645 creator A5074975947 @default.
- W2513256645 date "2016-07-13" @default.
- W2513256645 modified "2023-09-25" @default.
- W2513256645 title "Talimogen laherparepwek (T-VEC) — nowa terapia czerniaków skóry zmodyfikowanym genetycznie wirusem onkolitycznym" @default.
- W2513256645 doi "https://doi.org/10.5603/njo.2016.0039" @default.
- W2513256645 hasPublicationYear "2016" @default.
- W2513256645 type Work @default.
- W2513256645 sameAs 2513256645 @default.
- W2513256645 citedByCount "0" @default.
- W2513256645 crossrefType "journal-article" @default.
- W2513256645 hasAuthorship W2513256645A5052149622 @default.
- W2513256645 hasAuthorship W2513256645A5074975947 @default.
- W2513256645 hasBestOaLocation W25132566451 @default.
- W2513256645 hasConcept C121608353 @default.
- W2513256645 hasConcept C126322002 @default.
- W2513256645 hasConcept C143998085 @default.
- W2513256645 hasConcept C2777658100 @default.
- W2513256645 hasConcept C2777701055 @default.
- W2513256645 hasConcept C502942594 @default.
- W2513256645 hasConcept C535046627 @default.
- W2513256645 hasConcept C71924100 @default.
- W2513256645 hasConcept C82210918 @default.
- W2513256645 hasConceptScore W2513256645C121608353 @default.
- W2513256645 hasConceptScore W2513256645C126322002 @default.
- W2513256645 hasConceptScore W2513256645C143998085 @default.
- W2513256645 hasConceptScore W2513256645C2777658100 @default.
- W2513256645 hasConceptScore W2513256645C2777701055 @default.
- W2513256645 hasConceptScore W2513256645C502942594 @default.
- W2513256645 hasConceptScore W2513256645C535046627 @default.
- W2513256645 hasConceptScore W2513256645C71924100 @default.
- W2513256645 hasConceptScore W2513256645C82210918 @default.
- W2513256645 hasIssue "3" @default.
- W2513256645 hasLocation W25132566451 @default.
- W2513256645 hasOpenAccess W2513256645 @default.
- W2513256645 hasPrimaryLocation W25132566451 @default.
- W2513256645 hasRelatedWork W1977494725 @default.
- W2513256645 hasRelatedWork W2064247606 @default.
- W2513256645 hasRelatedWork W2064329086 @default.
- W2513256645 hasRelatedWork W2097000480 @default.
- W2513256645 hasRelatedWork W2408014536 @default.
- W2513256645 hasRelatedWork W3083422710 @default.
- W2513256645 hasRelatedWork W3084621851 @default.
- W2513256645 hasRelatedWork W3137403642 @default.
- W2513256645 hasRelatedWork W3149585669 @default.
- W2513256645 hasRelatedWork W3181883167 @default.
- W2513256645 hasVolume "66" @default.
- W2513256645 isParatext "false" @default.
- W2513256645 isRetracted "false" @default.
- W2513256645 magId "2513256645" @default.
- W2513256645 workType "article" @default.